Literature DB >> 25267483

Kupfer-type immunological synapses in vivo: Raison D'être of SMAC.

Izaskun Mitxitorena1, Elena Saavedra1, Carlos Barcia1.   

Abstract

T cells engage with antigen-presenting cells to form immunological synapses. These intimate contacts are characterized by the complex arrangement of molecules at the intercellular interface, which has been described as the supramolecular activation cluster (SMAC). However, due to T cells functioning without SMAC formation and the difficulties of studying these complex arrangements in vivo, its biological importance has been questioned. In light of recent data, we focus this review on the putative functionality of SMACs in T-cell synaptic contacts in vivo and emphasize the therapeutic potential of SMAC manipulation in immune-driven diseases.

Mesh:

Substances:

Year:  2014        PMID: 25267483     DOI: 10.1038/icb.2014.80

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  55 in total

1.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 2.  Dynamics of the immunological synapse: finding, establishing and solidifying a connection.

Authors:  Matthew F Krummel; Mark M Davis
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

3.  Dynamic polarization of the microtubule cytoskeleton during CTL-mediated killing.

Authors:  Jeffrey R Kuhn; Martin Poenie
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

4.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

5.  Subcellular dynamics of T cell immunological synapses and kinapses in lymph nodes.

Authors:  Georges A Azar; Fabrice Lemaître; Ellen A Robey; Philippe Bousso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

6.  Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells.

Authors:  Nicholas Stephen Rennie Sanderson; Mariana Puntel; Kurt M Kroeger; Niyati S Bondale; Mark Swerdlow; Niloufar Iranmanesh; Hideo Yagita; Ahmed Ibrahim; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

7.  T cell receptor signaling precedes immunological synapse formation.

Authors:  Kyeong-Hee Lee; Amy D Holdorf; Michael L Dustin; Andrew C Chan; Paul M Allen; Andrey S Shaw
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

8.  Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo.

Authors:  J Yang; N S R Sanderson; K Wawrowsky; M Puntel; M G Castro; P R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

9.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Authors:  Michael A Curran; Welby Montalvo; Hideo Yagita; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 10.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

View more
  1 in total

1.  Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.

Authors:  Laura R Díaz; Elena Saavedra-López; Leire Romarate; Izaskun Mitxitorena; Paola V Casanova; George P Cribaro; José M Gallego; Ana Pérez-Vallés; Jerónimo Forteza-Vila; Clara Alfaro-Cervello; José M García-Verdugo; Carlos Barcia; Carlos Barcia
Journal:  JCI Insight       Date:  2018-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.